188 related articles for article (PubMed ID: 12852433)
1. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.
Lipton SA
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S38-46. PubMed ID: 12852433
[TBL] [Abstract][Full Text] [Related]
2. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
Lipton SA
NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
4. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
5. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
6. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
Seki M; Lipton SA
Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey.
Hare W; WoldeMussie E; Lai R; Ton H; Ruiz G; Feldmann B; Wijono M; Chun T; Wheeler L
Surv Ophthalmol; 2001 May; 45 Suppl 3():S284-9; discussion S295-6. PubMed ID: 11377450
[TBL] [Abstract][Full Text] [Related]
9. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine.
Hare WA; Wheeler L
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2940-8. PubMed ID: 19136701
[TBL] [Abstract][Full Text] [Related]
10. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of memantine in different retinal injury models in rats.
WoldeMussie E; Yoles E; Schwartz M; Ruiz G; Wheeler LA
J Glaucoma; 2002 Dec; 11(6):474-80. PubMed ID: 12483089
[TBL] [Abstract][Full Text] [Related]
12. Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma.
Sánchez-López E; Egea MA; Davis BM; Guo L; Espina M; Silva AM; Calpena AC; Souto EMB; Ravindran N; Ettcheto M; Camins A; García ML; Cordeiro MF
Small; 2018 Jan; 14(2):. PubMed ID: 29154484
[TBL] [Abstract][Full Text] [Related]
13. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
14. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro.
Luo X; Heidinger V; Picaud S; Lambrou G; Dreyfus H; Sahel J; Hicks D
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1096-106. PubMed ID: 11274091
[TBL] [Abstract][Full Text] [Related]
15. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
16. Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia.
Koch HJ; Uyanik G; Fischer-Barnicol D
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):499-506. PubMed ID: 16266284
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity.
Wehrwein E; Thompson SA; Coulibaly SF; Linn DM; Linn CL
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1531-43. PubMed ID: 15111612
[TBL] [Abstract][Full Text] [Related]
18. Saving the nerve from glaucoma: memantine to caspaces.
Naskar R; Vorwerk CK; Dreyer EB
Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
